Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Berenson currently holds 7,508 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Berenson has been a net neutral trader of MRNA stock. They have purchased $0 and sold $0 worth of shares.
Stephen Berenson's most recent insider trade was on Jul 1, 2026, when they sold 7,508 shares at $0.00 per share.
Stephen Berenson serves as Executive at Moderna, Inc. (MRNA). They have executed 11 insider transactions totaling $0 over their tenure at the company.
Stephen Berenson holds the position of Executive at Moderna, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Stephen Berenson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Stephen Berenson was on Jul 1, 2026, when they purchased $0 worth of MCRB shares. This transaction involved 7,508 shares at N/A per share.
Stephen Berenson currently owns 7,508 shares of Moderna, Inc. (MRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Berenson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Berenson has 11 Form 4 filings on record as an insider at Moderna, Inc..
Set alerts for Stephen Berenson and 40,000+ other insiders.